Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
得意分野
Suggested News & Insights
DOJ Establishes Super Intelligence Task Force to Coordinate AI-Related EnforcementNovember 13, 2026Beyond the Ballot: What the 2026 Midterms Mean for Your BusinessThursday, November 12, 2026DOJ Announces $13 Million Settlement with Defense and Aerospace Contractors, Alleging Failures to Meet Cybersecurity RequirementsNovember 11, 2026Sidley’s Ian McGinley Discusses Prediction Markets, Insider Trading Risks, and CFTC Enforcement on GRIP PodcastNovember 11, 2026Beyond the Ballot: What the 2026 Midterms Mean for Your BusinessNovember 9, 2026DOJ and EEOC Announce $29.5 Million Two-Part Settlement with Lockheed Martin, the Fourth FCA Resolution Targeting Alleged Employment DiscriminationNovember 5, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
